Chronic Kidney Disease after Pediatric Hematopoietic Cell Transplant

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 1 SUPPL., 2008, Pages 84-87

  Hingorani, Sangeeta ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCINEURIN INHIBITOR; CAPTOPRIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ETOPOSIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RITUXIMAB;

APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SAFETY; GLOMERULUS FILTRATION RATE; GRAFT VERSUS HOST REACTION; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LABORATORY TEST; LEUKEMIA; MONOTHERAPY; NEPHROTIC SYNDROME; NEUROBLASTOMA; NONHUMAN; PERITONEAL DIALYSIS; RISK ASSESSMENT; RISK FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA;

CHILD; DISEASE MANAGEMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY FAILURE, CHRONIC; RISK FACTORS;

EID: 37349043649     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.11.008     Document Type: Article

References (42)

1. Cohen E., Lawton C., and Moulder J. Bone marrow transplant nephropathy: radiation nephritis revisited. Nephron 70 (1995) 217-222
2. Hingorani S., Guthrie K.A., Schoch G., Weiss N.S., and McDonald G.B. Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 39 (2007) 223-229
3. Weiss A.S., Sandamaier B.M., Storer B., Storb R., McSweeney P., and Parikh C.R. Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 6 (2006) 89-94
4. Tarbell N., Guinan E., Neimeyer C., Mauch P., Sallan S., and Weinstein H. Late onset of renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 15 (1988) 99-104
5. Antignac C., Gubler M.-C., Leverger G., Broyer M., and Habib R. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int 35 (1989) 1336-1344
6. Lawton C., Cohen E., Murray K., et al. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplant 20 (1997) 1069-1074
7. Pettitt A., and Clark R. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 14 (1994) 494-504
8. Schriber J., and Herzig G. Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Sem Hematol 42 (1997) 126-133
9. Atkinson K., Biggs J., Hayes J., et al. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes. Br J Haematol 54 (1983) 59-67
10. Zeigler Z., Rosenfeld C., Andrews III D., et al. Plasma von Willebrand Factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM). Am J Hematol 52 (1996) 213-220
11. Chappell M., Keeling D., Prentice H., and Sweny P. Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?. Bone Marrow Transplant 3 (1988) 339-347
12. Sarkodee-Adoo C., Sotirescu D., Sensenbrenner L., et al. Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. Transfusion 43 (2003) 78-84
13. Uderzo C., Fumagalli M., De Lorenzo P., et al. Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation. Bone Marrow Transplant 26 (2000) 1005-1009
14. Fuge R., Bird J., Fraser A., et al. The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. Br J Hematol 113 (2001) 58-64
15. Hahn T., Alam A., Lawrence D., et al. Thrombotic microangiopathy after allogeniec blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor and methylprednisolone T-cell depletion. Transplantation 78 (2004) 1515-1522
16. Daly A.S., Hasegawa W.S., Lipton J.H., Messner H.A., and Kiss T.L. Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver. Transfus Apher Sci 27 (2002) 3-12
17. Uderzo C., Bonanomi S., Busca A., et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation 82 (2006) 638-644
18. Van Why S., Friedman A., Wei L., and Hong R. Renal insufficiency after bone marrow transplantation in children. Bone Marrow Transplant 7 (1991) 383-388
19. Lonnerholm G., Carlson K., Bratteby L., et al. Renal function after autologous bone marrow transplantation. Bone Marrow Transplant 8 (1991) 129-134
20. Kist-van Holthe J., Goedvolk C., Brand R., et al. Prospective study of renal insufficiency after bone marrow transplantation. Pedatr Nephrol 17 (2002) 1032-1037
21. Gronroos M.H., Bolme P., Winiarski J., and Berg U.B. Long-term renal function following bone marrow transplantation. Bone Marrow Transplant 39 (2007) 717-723
22. Berg U., and Bolme P. Renal function in children following bone marrow transplantation. Transplant Proc 21 (1989) 3092-3094
23. Patzer L., Ringelmann F., Kentouche K., et al. Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Bone Marrow Transplant 27 (2001) 319-327
24. Kist-van Holthe J., van Zwet J., Brand R., van Weel M., Vossen J., and van der Heijden A. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 22 (1998) 559-564
25. Frisk P., Bratteby L., Carlson K., and Lonnerholm G. Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant 29 (2002) 129-136
26. Rao P. Nephrotic syndrome in patients with peripheral blood stem cell transplant. Am J Kidney Dis 45 (2005) 780-785
27. Brukamp K., Doyle A., Bloom R., Bunin N., Tomaszewski J., and Cizman B. Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?. Clin J Am Soc Nephrol 1 (2006) 685-694
28. Chan G.S.-W., Lam M., Au W., et al. IgA nephropathy complicating graft-vs-host disease, another nephropathy causing nephrotic syndrome after bone marrow transplantation. Histopathology 45 (2004) 642-656
29. Oliveira J., Bahia D., Franco M., Balda C., Stella S., and Kerbauy J. Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal. Bone Marrow Transplant 23 (1999) 99-101
30. Suehiro T., Masutani K., Yokoyama M., et al. Diffuse proliferative glomerulonephritis after bone marrow transplantation. Clin Nephrol 58 (2002) 231-237
31. Nouri-Majelan N., Sanadgol H., Ghafari A., Rahimian M., Mortazavizadeh M., and Moghaddasi S. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in chronic graft-versus-host disease after allogenic hematopoietic stem cell transplantation. Transplant. Proc 37 (2005) 3213-3215
32. Chien Y.-H., Lin K.-H., Lee T.-Y., Lu M.-Y., and Tsau Y.-K. Nephrotic syndrome in a bone marrow transplant recipient without chronic graft versus host disease. J Formos Med Assoc 99 (2000) 503-506
33. Reddy P., Johnson K., Uberti J.P., et al. Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 38 (2006) 351-357
34. Cohen E., Piering W., Kabler-Babbitt C., and Moulder J. End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compared to other causes of ESRD. Nephron 79 (1998) 408-412
35. Cohen E. Radiation nephropathy after bone marrow transplantation. Kidney Int 58 (2000) 903-918
36. Lopez Santi R., Valeff E., Duymovich C., et al. Effects of angiotensin converting enzyme inhibitor (ramipril) on inflammatory markers in secondary prevention patients: RAICES Study. Coron Artery Dis 16 (2005) 423-429
37. Dagenais N.J., and Jamali F. Protective effects of angiotensin II interruption: evidence for antiinflammatory actions. Pharmacotherapy 25 (2005) 1213-1229
38. Maschio G., Alberti D., Janin G., et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334 (1996) 939-945
39. Sica D.A., Gehr T.W., and Fernandez A. Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease. Drug Saf 22 (2000) 350-360
40. Thomas S., Hutchinson R., DebRoy M., and Magee J. Successful renal transplantation following prior bone marrow transplantation in pediatric patients. Pediatr Transplant (2004) 8
41. Butcher J., Hariharan S., Adams M., Johnson C., Roza A., and Cohen E. Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression. Clin Transplant 13 (1999) 330-335
42. Hamawi K., Magalhaes-Silverman M., and Bertolatus J. Outcomes of renal transplantation following bone marrow transplantation. Am J Transplant 3 (2003) 301-305